Legal & General Group PLC Aerie Pharmaceuticals Inc Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$6.37 - $15.23 $113,882 - $272,281	-17,878 Reduced 48.29%	19,147 $289,000
Q2 2022 Aug 22, 2022	BUY	$4.95 - $9.16 $100,143 - $185,315	20,231 Added 120.47%	37,025 $278,000
Q1 2022 May 16, 2022	BUY	$5.64 - $9.8 $840 - $1,460	149 Added 0.9%	16,794 $153,000
Q3 2021 Nov 15, 2021	BUY	$11.32 - $16.63 $99,502 - $146,177	8,790 Added 111.9%	16,645 $190,000
Q2 2021 Aug 12, 2021	BUY	$15.16 - $18.97 $6,124 - $7,663	404 Added 5.42%	7,855 $126,000
Q1 2021 May 17, 2021	SELL	$13.12 - $20.9 $148,203 - $236,086	-11,296 Reduced 60.25%	7,451 $133,000
Q3 2020 Nov 13, 2020	SELL	$10.46 - $14.46 $18,796 - $25,984	-1,797 Reduced 8.75%	18,747 $220,000
Q2 2020 Aug 14, 2020	SELL	$12.0 - $16.13 $6,492 - $8,726	-541 Reduced 2.57%	20,544 $303,000
Q1 2020 May 14, 2020	SELL	$11.84 - $25.52 $23,194 - $49,993	-1,959 Reduced 8.5%	21,085 $285,000
Q4 2019 Feb 13, 2020	BUY	$17.72 - $25.1 $30,372 - $43,021	1,714 Added 8.04%	23,044 $557,000
Q3 2019 Nov 13, 2019	BUY	$18.41 - $28.0 $29,971 - $45,584	1,628 Added 8.26%	21,330 $410,000
Q2 2019 Aug 14, 2019	BUY	$28.97 - $48.21 $56,868 - $94,636	1,963 Added 11.07%	19,702 $582,000
Q1 2019 May 15, 2019	BUY	$36.32 - $49.25 $5,339 - $7,239	147 Added 0.84%	17,739 $842,000
Q4 2018 Feb 15, 2019	BUY	$33.0 - $60.04 $192,324 - $349,913	5,828 Added 49.54%	17,592 $635,000
Q3 2018 Nov 20, 2018	SELL	$56.15 - $73.9 $10,780 - $14,188	-192 Reduced 1.61%	11,764 $724,000
Q2 2018 Aug 10, 2018	SELL	$47.85 - $70.45 $23,542 - $34,661	-492 Reduced 3.95%	11,956 $808,000
Q1 2018 May 17, 2018	SELL	$51.15 - $61.0 $105,573 - $125,904	-2,064 Reduced 14.22%	12,448 $675,000
Q4 2017 Feb 13, 2018	BUY	$50.85 - $65.1 $737,935 - $944,731	14,512	14,512 $872,000

Others Institutions Holding AERI

# of Institutions

Shares Held

2.4M

Call Options Held

Put Options Held

View Full List

About AERIE PHARMACEUTICALS INC

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

More about AERI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account